Hostname: page-component-7b7567c8c-7pwfn Total loading time: 0 Render date: 2026-11-16T08:02:40.903Z Has data issue: false hasContentIssue false

Battles Over Medication Abortion Threaten the Integrity of Drug Approvals in the U.S.

Published online by Cambridge University Press:  01 September 2023

Liam Bendicksen
Affiliation:
PORTAL, BRIGHAM AND WOMEN’S HOSPITAL, BOSTON, MA, USA
Aaron S. Kesselheim
Affiliation:
PORTAL, BRIGHAM AND WOMEN’S HOSPITAL, BOSTON, MA, USAHARVARD MEDICAL SCHOOL, BOSTON, MA, USA
Rights & Permissions [Opens in a new window]

Abstract

Legal challenges to the FDA’s approval of mifepristone have destabilized patients’ ability to access controversial medicines like medication abortion. We argue that federal courts’ receptiveness to this litigation undermines the coherence and integrity of prescription drug regulation in the U.S.

Information

Type
Columns: Health Policy Portal
Copyright
© 2023 The Author(s)